|
| Study | Peak AST, days 1–7, U/L, median (range) (NMP vs Control) | INR 1 week, median (range) (NMP vs Control) | Bilirubin 1 week, μmol/L, median (range) (NMP vs Control) | ALP 1 week, U/L, median (range) (NMP vs Control) |
|
| Ravikumar et al. [39] | 417 (84–4681) vs 902 (218–8786) () | 1.05 (0.88–1.40) vs 1.03 (0.90–2.22) () | 25 (8–211) vs 30 (9–221) () | 245 (81–568) vs 243 (76–743) () |
|
| Selzner et al. [42] | 619 (55–2858) vs 949 (233–3073) () | 1.1 (1–1.56) vs 1.1 (1–1.3) () | 25.6 (17.1–131.6) vs 47.53 (6.8–256.5) () | 202 (96–452) vs 147 (87–456) () |
|
| Bral et al. [43] | 1252 (383 to >2600) vs 839 (153 to >2600) () | 1.1 (1.1–1.6) vs 1.1 (0.9–1.5) () | 79 (17–344) vs 53 (8–340) () | 139 (40–626) vs 187 (58–524) () |
|
| Liu et al. [44] | NA () | NA | NA (P > 0.05) | NA |
|
| Nasralla et al. [45] | 488.1 (408.9–582.8) vs 964.9 (794.5–1172.0) () | 1.24 (1.15–1.38) vs 1.24 (1.16–1.39) () | 38.5 (21.0–73.2) vs 49.1 (26.0–85.5) () | NA |
|
